Dainippon Sumitomo

Dainippon Sumitomo is a top pharmaceutical company based in Osaka, Japan

Dainippon Sumitomo is a top pharmaceutical company based in Osaka, Japan.The company was formed as a merger between Dainippon Pharmaceuticals and Sumitomo Pharmaceuticals on October 1st 2005.

Dainippon Sumitomo is engaged in the discovery, development, manufacture and sale of pharmaceuticals worldwide.

Report: Partnering Deals and Alliances with Dainippon Sumitomo

Dainippon Sumitomo is a top pharmaceutical company based in Osaka, Japan.

The company was formed as a merger between Dainippon Pharmaceuticals and Sumitomo Pharmaceuticals on October 1st 2005.

Dainippon Sumitomo is engaged in the discovery, development, manufacture and sale of pharmaceuticals worldwide.

The company has four core businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

Pharmaceuticals – the company offers branded and generic medicines, using packaging enhancements, new formulations and innovative drug delivery technologies.

Diagnostics & Research Materials – the company develops and supplies point-of-care testing (POCT) products, in-vitro diagnostics and supplies research materials that facilitate research related to medical care.

Animal Health Products – the company manufactures veterinary medicines for companion animals, primarily dogs and cats, as well as for farm animals such as cattle, swine, horses and cultured fish.

Food Ingredients & Chemical Products – the company develops and sells ingredients and additives for use in manufacturing safe, high-quality foods. The chemical product materials business encompasses such products as cosmetic materials, active pharmaceutical ingredients, electronic chemicals and coating materials.

Dainippon Sumitomo has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities Dainippon Sumitomo has a long history of partnering, building numerous collaborative partnerships

Dainippon Sumitomo announced 25 partnering / licensing deals since 2005, with over 8 deals in 2008 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in CNS disorders, Psychiatry, respiratory, immunology and metabolic disorders

Dainippon Sumitomo has also announced 2 M&A deals since 2005, agreeing the acquisition of Boston Biomedical and Sepracor.

Report: Partnering Deals and Alliances with Dainippon Sumitomo

Examples of recent partnering and licensing deals announced by Dainippon Sumitomo can be viewed in Current Partnering's Partnering Agreements with Dainippon Sumitomo 2005-2013 partnering activity review article.

Examples of recent M&A deals announced by Dainippon Sumitomo can be viewed in Current Partnering's Partnering Agreements with Dainippon Sumitomo 2005-2013  M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Dainippon Sumitomo

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Dainippon Sumitomo

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Dainippon Sumitomo

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Dainippon Sumitomo company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email